Coloplast B A/S
Coloplast B A/S
0,64 %
844,80 DKK
5,40
Kurs
844,80
Høj
844,80
Ændring
0,64 %
Lav
830,80
Opdateret
21-08-2019
Åben
839,00
Nyheder om Coloplast B A/S
Factsheet for Coloplast B A/S
Company Profile
Description
Coloplast A/S is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.
Key Stats
Website: http://www.coloplast.com
Headquarter country: Denmark
Employees: 8.000
Market Cap (at close 20-08-2019): DKK 178B
Fiscal Year Ends: september
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 33,40 27,60 32,20 132,60 46,30
Forward Price/Earnings 29,20 26,10 25,40 32,10 32,40
Price/Free Cash Flow 34,80 40,90 42,50 43,80 42,30
Return on Assets 32,30 32,90 28,80 8,50 24,20
Return on Equity 62,20 68,90 64,30 16,40 36,60
Return on Invested Capital 50,70 59,30 62,00 16,00 35,60
Dividend


Dividend/Share:15,50
Ex. Dividend Date:30-09-2018
Trailing Dividend Yield:1,94
Payout Ratio:82,69
Date Currency Amount
30-06-2019 DKK 5,00
31-12-2018 DKK 11,00
30-06-2018 DKK 5,00
31-12-2017 DKK 10,50
30-06-2017 DKK 4,50
31-12-2016 DKK 9,00
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 16.449,00 15.528,00 14.681,00 13.909,00 12.428,00
Gross Profit 11,07 10,57 10,03 9,53 8,54
Gross Margin % 67,27% 68,08% 68,33% 68,54% 68,70%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 5.646,00 5.573,00 4.619,00 1.735,00 3.620,00
Net income 3.845,00 3.797,00 3.143,00 899,00 2.390,00
Basic Earnings Per Share 18,12 17,91 14,80 4,30 11,30
Operating Income 5,09 5,02 4,85 4,54 4,15
Operating Margin % 30,95% 32,35% 33,01% 32,60% 33,37%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 4.361,00 3.251,00 3.028,00 3.337,00 3.149,00
Capital Expenditures -669,00 -685,00 -649,00 -617,00 -533,00
Free Cash Flow 3.692,00 2.566,00 2.379,00 2.720,00 2.616,00
Balance Sheet

Assets 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Current Assets
Long Term Assets
Total Assets
Liabilities 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Total Current Liabilities
Long Term Liabilities
Total Liabilities
Equity 31-12-2018 31-12-2017 31-12-2016 31-12-2015 31-12-2014
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets